HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CP 751871

an anti-insulin-like growth factor-I receptor monoclonal antibody in Phase I clinical trials
Also Known As:
CP 751,871; CP-751,871; CP-751871; CP751,871; CP751871
Networked: 12 relevant articles (0 outcomes, 6 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Gualberto, Antonio: 5 articles (05/2009 - 03/2005)
2. Haluska, Paul: 3 articles (05/2009 - 06/2007)
3. Sharma, Amarnath: 2 articles (07/2008 - 10/2007)
4. Yin, Donghua: 2 articles (07/2008 - 10/2007)
5. de Bono, Johann S: 2 articles (10/2007 - 06/2007)
6. Prous, J R: 2 articles (09/2007 - 06/2007)
7. Rabasseda, X: 2 articles (09/2007 - 06/2007)
8. Koumenis, Constantinos: 1 article (07/2011)
9. El-Deiry, Wafik S: 1 article (07/2011)
10. Christensen, James G: 1 article (07/2011)

Related Diseases

1. Neoplasms (Cancer)
2. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
3. Prostatic Neoplasms (Prostate Cancer)
4. Multiple Myeloma
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Paclitaxel (Taxol)
2. IGF Type 1 Receptor (IGF 1 Receptor)
3. Carboplatin (JM8)
4. Insulin (Novolin)
5. Prednisone (Sone)
6. Hormones
7. docetaxel (Taxotere)
8. exemestane (Aromasin)
9. ISIS 301012
10. fluticasone furoate

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Stents